Epidemiological situation of mycobacterioses in Ukraine and the worldwide at the beginning of the 21st century: A literature review

  • Received 31.01.2024

  • Revised 17.04.2024

  • Accepted 28.05.2024



  • 1,041 Views

  • Retrieved from Vol. 6, No. 2, 2024

  • Pages 76-84

The lack of a unified reporting system for clinical outbreaks of mycobacterioses makes it difficult to objectively assess the epidemiological situation and identify patterns in the epidemic process, despite the growing relevance of this issue in human and veterinary medicine. The aim of this review was to study the epidemiological and aetiopathogenetic aspects of mycobacterioses in Ukraine and other countries on different continents. A comparative-geographic method and epidemiological analysis method were used in the study. As a result, it was found that in Ukraine, mycobacterioses in humans are widespread, with 94% of cases manifesting as pulmonary forms, often forming mixed infections with tuberculosis, making them difficult to diagnose. The most common aetiological factor is M. avium complex and disseminated mycobacteriosis usually develops in HIV-infected patients. In most of the analysed countries (Japan, South Korea, Iran, Turkey, Pakistan, Saudi Arabia, Egypt, Oman, Kuwait, China, France, Great Britain, Italy, Greece, Czech Republic, Poland, USA, Canada, Brazil, Australia and several African countries) during the period 2000-2023, there was an observed increase in the incidence of lung diseases caused by non-tuberculous mycobacteria, including an 8-fold rise in South Korea; an annual growth of 8% in the USA; and a 2.3-fold increase in Queensland (Australia) from 11.1 pcm in 2001 to 25.88 pcm in 2016. It was established that the epidemiological features of mycobacterioses are the predominant infection of patients with rapidly growing mycobacteria; an increased risk of mycobacterial infection with increasing age; detection of M. avium complex, M. abscessus complex, M. kansasii and M. fortuitum as the most common cause of mycobacterioses

human mycobacterioses; nontuberculous mycobacteria; epidemiology of mycobacterioses; M. avium complex

https://doi.org/10.61751/bmbr/2.2024.76

[1] Global tuberculosis report 2022 [Internet]. [cited 2024 Apr 16]. Available from:https://iris.who.int/handle/10665/363752

[2] Lipman M, Cleverley J, Fardon T, Musaddaq B, Peckham D, van der Laan R, et al. Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. BMJ Open Respir Res. 2020;7: 7:e000591. DOI: 10.1136/bmjresp-2020-000591 

[3] Gross JE, Caceres S, Poch K, Hasan NA, Jia F, Epperson LE, et al. Investigating nontuberculous mycobacteria transmission at the Colorado Adult Cystic Fibrosis Program. Am J Respir Crit Care Med. 2022;205(9):1064–74. DOI: 10.1164/rccm.202108-1911OC

[4] Alffenaar JW, Märtson AG, Heysell SK, Cho JG, Patanwala A, Burch G, et al. Therapeutic drug monitoring in non-tuberculosis mycobacteria infections. Clin Pharmacokinet. 2021;60(6):711–25. DOI: 10.1007/s40262-021-01000-6

[5] Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27:74. DOI: 10.1186/s12929-020-00667-6

[6] Wu ML, Aziz DB, Dartois V, Dick T. NTM drug discovery: Status, gaps and the way forward. Drug Discov Today. 2018;23(8):1502–19. DOI: 10.1016/j.drudis.2018.04.001

[7] Drummond WK, Kasperbauer SH. Nontuberculous mycobacteria: Epidemiology and the impact on pulmonary and cardiac disease. Thorac Surg Clin. 2019;29(1):59–64. DOI: 10.1016/j.thorsurg.2018.09.006

[8] Pavlik I, Ulmann V, Weston RT. Clinical relevance and environmental prevalence of Mycobacterium fortuitum group members. Comment on Mugetti et al. Gene sequencing and phylogenetic analysis: powerful tools for an improved diagnosis of fish mycobacteriosis caused by Mycobacterium fortuitum group members. Microorganisms. 2021;9(11):2345. DOI: 10.3390/microorganisms9112345

[9] Zavgorodnii A, Bilushko V, Kalashnyk M, Pozmogova S, Kalashnyk N. Pseudo-allergic reactions to tuberculin in cattle. Vet Biotechnol. 2018;32:176–84.DOI: 10.31073/vet_biotech32(2)-20

[10] Turko I, Kulyaba O, Semanyuk V, Pelenyo R. Circulation of atypical mycobacteria in the environment and the organism as a cause of positive allergic reactions. Sci Mess Lviv Natl Univ Vet Med Biotechnol S Z Gzhytskyj. 2010;12(3-1):274–80.

[11] Boiko P, Nychyk S, Boiko O, Mandygra I. Some peculiarities of mycobacteriosis infectious and epizootic process in cattle caused by atypical acid-resistant mycobacteria. Vet Biotechnol. 2020;37:7–19. DOI: 10.31073/vet_biotech37-01

[12]  Bolaños CAD, Franco MMJ, Souza Filho AF, Ikuta CY, Burbano-Rosero EM, Ferreira Neto JS, et al. Nontuberculous mycobacteria in milk from positive cows in the intradermal comparative cervical tuberculin test: Implications for human tuberculosis infections. Rev Inst Med Trop Sao Paulo. 2018;60. DOI: 10.1590/s1678-9946201860006

[13] Busol V, Boiko P, Bednarski M, Shevchuk V, Mazur V. Pathomorphological changes in the organs of the peripheral immune system in mycobacteriosis of cattle. Ukr J Vet Sci. 2023;14(2):9–27. DOI: 10.31548/veterinary2.2023.09

[14] Todoriko L, Shevchenko O. Modern aspects of pulmonary mycobacteriosis (analytical review). Act Infectol. 2022;(4.13):13–21. DOI: 10.22141/2312-413x.4.13.2016.91449

[15] Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: Clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series. Chest. 2022;161(3):637–46. DOI: 10.1016/j.chest.2021.10.003

[16] Shin JI, Shin SJ, Shin MK. Differential genotyping of Mycobacterium avium complex and its implications in clinical and environmental epidemiology. Microorganisms. 2020;8(1):98. DOI: 10.3390/microorganisms8010098

[17] Zhurilo O, Barbova A, Sladkova L. Mycobacterium avium as pathogen of human mycobacteriosis. Ukr Pulmonol J. 2020;1:50–58. DOI: 10.31215/2306-4927-2020-107-1-50-58

[18] Merritt RW, Walker ED, Small PLC, Wallace JR, Johnson PDR, Benbow ME, et al. Ecology and transmission of Buruli ulcer disease: A systematic review. PLoS Negl Trop Dis. 2010;4(12). DOI: 10.1371/journal.pntd.0000911

[19] Thomson RM, Furuya-Kanamori L, Coffey C, Bell SC, Knibbs LD, Lau CL. Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001-2016. Sci Total Environ. 2020;740:139796. DOI: 10.1016/j.scitotenv.2020.139796

[20] Daley CL, Griffith DE. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis. 2010;14(6):665–71.

[21] Zhurilo O, Barbova A. Modern state and prospects of diagnostics of lung diseases caused by nontuberculous mycobacteria. Tuberc Lung Dis HIV Infect. 2019;1:73–80.

[22] Aubry A, Mougari F, Reibel F, Cambau E. Mycobacterium marinum. Microbiol Spectr. 2017;5(2). DOI: 10.1128/microbiolspec.TNMI7-0038-2016

[23] Strollo SE, Adjemian J, Adjemian MK, Prevots DR. The burden of pulmonary nontuberculous mycobacterial disease in the United States. Ann Am Thorac Soc. 2015;12(10):1458–64. DOI: 10.1513/AnnalsATS.201503-173OC

[24]  Yarchuk B, Verbytskyi P, Lytvyn V, Kornienko L, Litvin V, Kornienko L, et al. General epizootiology. Bila Tserkva; 2002. 656 p.

[25]  Peters M, Müller C, Rüsch-Gerdes S, Seidel C, Göbel U, Pohle HD, Ruf B. Isolation of atypical mycobacteria from tap water in hospitals and homes: Is this a possible source of disseminated MAC infection in AIDS patients? J Infect. 1995;31(1):39–44. DOI: 10.1016/s0163-4453(95)91333-5

[26]  Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23(3):529–51. DOI: 10.1016/s0272-5231(02)00014-x

[27]  Shevchenko O, Todoriko L, Poteyko P, Pogorelova O. Issues of diagnosis and treatment of non-tuberculous mycobacteriosis. Diagn Infect Dis. 2019;1(10):36–53. DOI: 10.15407/internalmed2019.01.036

[28] Tran QT, Han XY. Subspecies identification and significance of 257 clinical strains of Mycobacterium avium. J Clin Microbiol. 2014;52. DOI: 10.1128/jcm.03399-13

[29] Falkinham JO 3rd, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67(3):1225–31. DOI: 10.1128/AEM.67.3.1225-1231.2001

[30] Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019;152:74–80. DOI: 10.1016/j.rmed.2019.05.001

[31] Ko RE, Moon SM, Ahn S, Jhun BW, Jeon K, Kwon OJ, et al. Changing epidemiology of nontuberculous mycobacterial lung diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015. J Korean Med Sci. 2018;33(8):e65. DOI: 10.3346/jkms.2018.33.e65

[32] Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J, Pang Y. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016. BMC Pulm Med. 2018;18:168. DOI: 10.1186/s12890-018-0728-z

[33] Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in the Middle East: Current situation and future challenges. Int J Mycobacteriol. 2015;4(1):7–17. DOI: 10.1016/j.ijmyco.2014.12.005

[34] Shrivastava K, Kumar C, Singh A, Narang A, Giri A, Sharma NK, et al. An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region. Int J Mycobacteriol. 2020;9(1):62–70. DOI: 10.4103/ijmy.ijmy_179_19

[35] Norton GJ, Williams M, Falkinham JO 3rd, Honda JR. Physical measures to reduce exposure to tap water–associated nontuberculous mycobacteria. Front Public Health. 2020;8:190. DOI: 10.3389/fpubh.2020.00190

[36] Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, et al. Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013. Emerg Infect Dis. 2017;23(3):468–76. DOI: 10.3201/eid2303.161927

[37] Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect. 2016;72(6):678–86. DOI: 10.1016/j.jinf.2016.03.008

[38] Carneiro MDS, Nunes LS, David SMM, Dias CF, Barth AL, Unis G. Nontuberculous mycobacterial lung disease in a high tuberculosis incidence setting in Brazil. J Bras Pneumol. 2018;44(2):106–11. DOI: 10.1590/s1806-37562017000000213

[39] Prevots DR, Marshall JE, Wagner D, Morimoto K. Global epidemiology of nontuberculous mycobacterial pulmonary disease: A review. Clin Chest Med. 2023;44(4):675–21. DOI: 10.1016/j.ccm.2023.08.012

[40] Panagiotou M, Papaioannou AI, Kostikas K, Paraskeua M, Velentza E, Kanellopoulou M, et al.. The epidemiology of pulmonary nontuberculous mycobacteria: Data from a general hospital in Athens, Greece, 2007-2013. Pulm Med. 2014;2014:894976. DOI: 10.1155/2014/894976 

[41] Blanc P, Dutronc H, Peuchant O, Dauchy FA, Cazanave C, Neau D, et al. Nontuberculous mycobacterial infections in a French hospital: A 12-year retrospective study. PLoS One. 2016;11(12):e0168290. DOI: 10.1371/journal.pone.0168290

[42] Przybylski G, Bukowski J, Kowalska W, Pilaczyńska-Cemel M, Krawiecka D. Trends from the last decade with nontuberculous mycobacteria lung disease (NTM-LD): Clinicians’ perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland. Pathogens. 2023;12(8):988. DOI: 10.3390/pathogens12080988

[43] Rindi L, Garzelli C. Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis. 2015;16:44. DOI: 10.1186/s12879-016-1380-y

[44] Modrá H, Ulmann V, Caha J, Hübelová D, Konečný O, Svobodová J, et al. Socio-economic and environmental factors related to spatial differences in human non-tuberculous Mycobacterial diseases in the Czech Republic. Int J Environ Res Public Health. 2019;16(20):3969.DOI: 10.3390/ijerph16203969

[45] Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. Scand J Infect Dis. 2012;44(11):815–19. DOI: 10.3109/00365548.2012.694469

[46] Zomer D, van Ingen J, Hofland R; Dutch CF Registry Steering group. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands. J Cyst Fibros. 2023;22(2):327–33. DOI: 10.1016/j.jcf.2022.10.009

[47] Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W. Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One. 2013;8(5). DOI: 10.1371/journal.pone.0063170

[48] Buijtels PC, van-der-Sande MA, de-Graaff CS, Parkinson S, Verbrugh HA, Petit PL. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis. 2009;15(2):242–49. DOI: 10.3201/eid1502.080006  

[49] Okoi C, Anderson STB, Antonio M, Mulwa SN, Gehre F, Adetifa IMO. Non-tuberculous mycobacteria isolated from pulmonary samples in sub-Saharan Africa: A systematic review and meta-analyses. Sci Rep. 2017;7:12002. DOI: 10.1038/s41598-017-12175-z